Oral intake of mushroom beta-glucan in tumor-bearing mice demonstrated an increase in the gene expression of IL-12 and IFN-γ in tumor tissues and a decrease in serum TGF-β concentration and gene expressions of IL-6, IL-10, COX-2, and TGF-β in the tumor microenvironment. Here, IL10 is linked to neoplasm.